 |
| AUGUST
4, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
- Agilent: Expands the Dako Omnis Family With
Three New Models to Meet Evolving Pathology
Lab Needs More
- American Cancer Society and Guardant Health:
Partner to Expand Cancer Screening Access and
Advance Health Equity More
- Anixa Biosciences: Commencement of US FDA
Approved IND Transfer to Support Upcoming
Phase 2 Breast Cancer Vaccine Trial More
- BioCardia: Update on Timing of Regulatory
Activities Seeking FDA Approval and Japan PMDA
Approval for CardiAMP Cell Therapy for Heart
Failure and Helix Transendocardial Delivery
Catheter More
- Exicure: Completes the Last Patient, Last
Visit in Phase 2 Study of GPC-100 for Stem
Cell Mobilization in Multiple Myeloma Patients
Undergoing Autologous Transplant More
- Genentech: Susvimo Maintains Vision Over
Five Years With Two Refills Per Year in
People With Wet Age-Related Macular
Degeneration (AMD) More
- Marea Therapeutics: Enrolls First Patient in
Phase 2b TYDAL-TIMI 78 Clinical Study
Evaluating MAR001 in Adults at Risk of ASCVD More
- NeuroPace: Commends
CMS for Maintaining FY25 Reimbursement
Structure for Epilepsy With Neurostimulator
Cases More
- PacBio: Nature
Methods Paper Leverages Sequencing Technology
to Develop the Platinum Pedigree Benchmark, a
New Standard for Accurate Characterization of
Variation in the Human Genome that Improves
Training for AI Models More
- Tenon Medical: Expands Sacro-Pelvic Fusion
Portfolio With Strategic Asset Acquisition More
|
|
 |
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- Phynx Lab: AI Startup Secures $4 Million
in Funding Round Led by SK Networks, With
Participation From Aidan Gomez, Illia
Polosukhin, and Other Notable Angel
Investors More
- HilleVax: Enters Into a Definitive
Agreement to be Acquired by XOMA Royalty for
$1.95 in Cash per Share Plus a Contingent
Value Right More
More
- ORIC Pharmaceuticals: Inducement Grants
Under Nasdaq Listing Rule 5635(c)(4) More
- Top 10 U.S. Biopharma Clusters 2025 More
- XOMA
Royalty: Enters Into Agreement to Acquire
LAVA Therapeutics for Between $1.16 and
$1.24 Per Share in Cash, Plus a Contingent
Value Right More
|
|
 |
| San
Francisco's most flexible contract
vivarium lab space: Start with a
few cages and grow. |
|
Learn More
→ |
|
|
- Subscribe to LifeSci Startup for
Updates on US Startups More
- 23andMe: Why Do People Stutter? Genetics
Holds Some Clues More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- Feature: CEO's Perspective: The Power of
Pivoting More
- ICYMI: What Defines Great Leadership? More
- ICYMI: The Future of Hiring: How Fractional
Talent is Reshaping The Workforce More
- ICYMI:Beyond Cautious Optimism: Why a Hybrid
Talent Model is the Future for Life Sciences
& Healthcare More
- Reimagining Life Sciences Roles With AI and
Automation More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
